CARLSMED, INC.
Data quality: 83%
CARL
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$9.65
▼
$0.35
(-3.45%)
Mkt Cap: 257.96 M
Price
$9.65
Mkt Cap
257.96 M
Day Range
$9.51 — $9.82
52-Week Range
$8.87 — $17.19
Volume
21,269
Open $9.59
50D / 200D Avg
$11.70
17.51% below
50D / 200D Avg
$12.93
25.35% below
Quick Summary
Key Takeaways
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -29.62 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-251.27%
Below sector avg (-53.47%)
ROIC-28.80%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.14
Below sector avg (0.31)
Current Ratio12.03
Interest Coverage-21.38
Valuation
PE (TTM)
-8.70
Below sector avg (-1.47)
P/B Ratio2.42
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.7 | -1.5 |
| P/B | 2.4 | 1.6 |
| ROE % | -251.3 | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | 0.1 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -29.63 M |
| ROE | -251.27% | ROA | -31.50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -29.62 M |
| ROIC | -28.80% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 12.03 |
| Interest Coverage | -21.38 | Asset Turnover | N/A |
| Working Capital | 120.54 M | Tangible Book Value | 106.66 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.70 | Forward P/E | N/A |
| P/B Ratio | 2.42 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -11.48% | ||
| Market Cap | 257.96 M | Enterprise Value | 158.03 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.12 | Revenue / Share | N/A |
| FCF / Share | -1.11 | OCF / Share | -1.08 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 99.95% |
| SBC-Adj. FCF | -31.55 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | — |
| Net Income | -29.63 M |
| EPS (Diluted) | -2.12 |
| Gross Profit | 38.04 M |
| Operating Income | -30.57 M |
| EBITDA | — |
| R&D Expenses | 17.02 M |
| SG&A Expenses | — |
| D&A | 281,000.0 |
| Interest Expense | 1.43 M |
| Income Tax | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 130.12 M |
| Total Liabilities | 31.25 M |
| Shareholders' Equity | 98.87 M |
| Total Debt | 15.35 M |
| Cash & Equivalents | 85.79 M |
| Current Assets | 126.67 M |
| Current Liabilities | 14.28 M |
{"event":"ticker_viewed","properties":{"ticker":"CARL","listing_kind":"stock","pathname":"/stocks/carl","exchange":"Nasdaq","country":"US"}}